Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice
- 1 January 2012
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 64 (1-2) , 109-114
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
This publication has 35 references indexed in Scilit:
- Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate–Salt HypertensionHypertension, 2007
- NADPH oxidaseCurrent Opinion in Immunology, 2004
- Resistance of young gelatinase B–deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesionsJournal of Clinical Investigation, 1999
- NADPH Oxidase: An UpdateBlood, 1999
- The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple SclerosisJournal of Neuropathology & Experimental Neurology, 1996
- Matrix metalloproteinases degrade myelin basic proteinNeuroscience Letters, 1995
- Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brainsAnnals of Neurology, 1994
- Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic proteinJournal of Neuroscience Research, 1993
- Increased generation of superoxide radicals in the blood of MS patientsActa Neurologica Scandinavica, 1993
- Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disordersJournal of Neuroimmunology, 1992